Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.81 |
| ▸ | FAAH | O00519 | 5/20 | 0.64 |
| ▸ | NAAA | Q02083 | 1/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25413301 | 1.00 | DNM1 (0.81) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9549506 | 1.00 | DNM1 (0.81) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL25413209 | 1.00 | DNM1 (0.81) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9487043 | 0.98 | DNM1 (0.78) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9549382 | 0.98 | DNM1 (0.78) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL30130591 | 0.97 | DNM1 (0.76) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL30130593 | 0.97 | DNM1 (0.76) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL31325297 | 0.95 | DNM1 (0.73) | DNM1FAAHNAAACASP2EPHX2 | |
| SCHEMBL9549308 | 0.95 | DNM1 (0.73) | DNM1FAAHNAAACASP2EPHX2 | |
| Bromide SCHEMBL11566193 | 0.94 | DNM1 (0.71) | DNM1FAAHNAAACASP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250109277-A1 | CYCLIC OLEFIN RESIN COMPOSITION, MOLDED ARTICLE, AND OPTICAL COMPONENT | MITSUI CHEMICALS, INC. (JP) | 2025-04-03 | — | — | US | disclosed |
| WO-2023153302-A1 | CYCLIC OLEFIN RESIN COMPOSITION, MOLDED ARTICLE AND OPTICAL COMPONENT | 三井化学株式会社 | 2023-08-17 | — | — | WO | disclosed |
| US-20160362539-A1 | ANTISTATIC AGENT, MOLDED ARTICLE COMPRISING AN INSULATING POLYMER MATERIAL, AND METHOD OF PRODUCING THE MOLDED ARTICLE | BORON LABORATORY CO., LTD. (JP) | 2016-12-15 | — | — | US | disclosed |
| US-7538248-B2 | Amineoxide type surfactant and detergent composition comprising it | AEKYUNG INDUSTRIAL CO., LTD. (KR) | 2009-05-26 | — | — | US | disclosed |
| US-20080039655-A1 | Amineoxide Type Surfactant and Detergent Composition Comprising It | AEKYUNG INDUSTRIAL CO., LTD. (KR) | 2008-02-14 | — | — | US | disclosed |
| WO-2006091011-A1 | AMINEOXIDE TYPE SURFACTANT AND DETERGENT COMPOSITION COMPRISING IT | AEKYUNG INDUSTRIAL CO., LTD. (KR) | 2006-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362539-A1 | ANTISTATIC AGENT, MOLDED ARTICLE COMPRISING AN INSULATING POLYMER MATERIAL, AND METHOD OF PRODUCING THE MOLDED ARTICLE | H1-2, MCM6, H1-0 | DNM1 3638/4885FAAH 1442/4885NAAA 1399/4885 |
| US-20080039655-A1 | Amineoxide Type Surfactant and Detergent Composition Comprising It | ABHD12, H1-2, H1-0 | DNM1 1586/4885FAAH 129/4885NAAA 284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.